Difference between revisions of "Template:ToLongActing"
From Psychiatrienet
m (moved Template:LongActing to Template:ToLongActing) |
|||
| Line 1: | Line 1: | ||
| − | * '''Note''': The safest way to switch to a long acting formulation, is to | + | * '''Note''': |
| + | 1. The safest way to switch to a long acting formulation, is first to switch to an oral formulation of the drug and after reaching a steady state switch to the depot. | ||
| + | |||
| + | 2. With a direct switch to a depot it is advisable to administer a low testdose in order to exclude adverse reactions. | ||
Latest revision as of 10:55, 28 January 2013
- Note:
1. The safest way to switch to a long acting formulation, is first to switch to an oral formulation of the drug and after reaching a steady state switch to the depot.
2. With a direct switch to a depot it is advisable to administer a low testdose in order to exclude adverse reactions.
